Eli Lilly's next leg of growth may have less to do with how well its weight loss drugs work and more to do with how many ...

Wall Street is getting more bullish on the pharma giant's shares.

Roughly $400 billion. That is how much market value Eli Lilly (NYSE:LLY | LLY Price Prediction) has added over the past year, with shares climbing from $773.86 on July 2, 2025 to $1,213.91 on July 2, ...

The stock has surged 160% over the past three years. Meanwhile, two key drugs could continue driving rampant growth.

CNBC's Angelica Peebles reports on Eli Lilly's stock performance. Got a confidential news tip? We want to hear from you. Sign ...

Eli Lilly (NYSE: LLY) stock has been rallying in recent months, taking off from around $850 in late April to more than $1,200 as of Monday's close, for an increase of more than 40% over that stretch.

Drug stocks got hit hard on Monday in what Jim Cramer called a “vicious rotation,” and the selloff looked like the usual crowded-trade unwind. Investors decided the Mounjaro story was played out. On ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The trial results are among the pharmaceutical ...

Let's get to the bottom of the intense ending of Eli on Netflix, shall we? Warning: This post contains major spoilers for Netflix's Eli. When Eli's parents take the young boy to a "clean house" run by ...

On Thursday, the Twitter account @EliLillyandCom that had a verified blue check mark posted, “We are excited to announce insulin is free now.” That account turned out to be a fake Eli Lilly and ...